Everyone at BIOLIFE4D is proud to announce our newest addition to our executive team, Kate Lewis. A pharmaceutical veteran and our company’s first female executive, Kate will proudly lead commercialization efforts of BIOLIFE4D’s live-saving 3D bioprinting technologies.
Kate brings more than 25 years of experience and relationships from within the pharmaceutical, transplantation, and regulatory industries. Her work included refining market development initiatives within pharma, research and advocacy organizations, and medical associations, helping to build strategic brand awareness while optimizing performance outcomes.
Prior to BIOLIFE4D, Kate was Founder of Nottingham Associates, a consulting firm focused on strategic client solutions for Pharma. Her work included refining market development initiatives and building Key Opinion Leader (KOL) boards within the pharmaceutical industry, clinical research, medical associations, and advocacy organizations.
Another significant accomplishment was assisting to increase market share of the number one treatment of asthma globally and contributing to the improvement in quality-of-life for countless individuals suffering from asthma. Additionally, through a collaboration with Harvard University and GSK, Kate also helped design a groundbreaking study – “Asthma in America” – which helped identify 4.3 million individuals with previously undiagnosed asthma.
Accomplished in her field, she has served as an active Board member on the American Lung Association and has been a GlaxoSmithKline (“GSK”) President’s Club Award winner for many years. The strength of her relationships in the pharmaceutical and medical communities and her gift of communicating complex issues and technologies to the public is part of what Kate brings to BIOLIFE4D.
Kate has come full circle in her mission to advance the health and wellness of others. Having lost her husband to a heart attack and her father to lung disease as a child, she has dedicated her professional career to education and advancing therapies which improve the quality-of-life for others. Kate’s other passions include being involved in community, philanthropic and humanitarian activities. These include being a founder and serving on the Board of Home of the Sparrow for abused and battered women and spearheading medical relief efforts and humanitarian aid for both Hurricane Irma and Maria survivors in the Caribbean. Kate also enjoys spending time with her two Sons and extended Family.
“This is such an exciting time for BIOLIFE4D, and I’m thrilled to accept the challenge of leading the Company into its first growth stage, toward commercialization of our pioneering 3D bioprinting technologies,” said Lewis. “From treatments like valve replacement and cardiac patches, to full-on heart transplants, to clinical research and testing – the market for 3D bioprinting and tissue engineering technologies has never been more significant. We’re excited to continue pushing our technology forward to make organ replacement a safe, accessible, and affordable reality.”
“We are tremendously pleased to have Kate join our team not only as our very first President but also as our first female executive” said Steven Morris, CEO, “From the day Kate joined our efforts to provide life-saving options to countless individuals world-wide she has proven herself to be as knowledgeable as she is passionate, and her leadership has helped to shape our commercialization strategy moving forward.”